BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9205049)

  • 1. Deficient transforming growth factor-beta1 activation and excessive insulin-like growth factor II (IGFII) expression in IGFII receptor-mutant tumors.
    Wang S; Souza RF; Kong D; Yin J; Smolinski KN; Zou TT; Frank T; Young J; Flanders KC; Sugimura H; Abraham JM; Meltzer SJ
    Cancer Res; 1997 Jul; 57(13):2543-6. PubMed ID: 9205049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells.
    Souza RF; Wang S; Thakar M; Smolinski KN; Yin J; Zou TT; Kong D; Abraham JM; Toretsky JA; Meltzer SJ
    Oncogene; 1999 Jul; 18(28):4063-8. PubMed ID: 10435587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
    Ghahary A; Tredget EE; Shen Q
    J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
    Ghahary A; Tredget EE; Mi L; Yang L
    Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts.
    Rosenthal E; McCrory A; Talbert M; Young G; Murphy-Ullrich J; Gladson C
    Mol Carcinog; 2004 Jun; 40(2):116-21. PubMed ID: 15170816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-beta type II receptor, IGFII receptor, and BAX genes.
    Iacopetta BJ; Soong R; House AK; Hamelin R
    J Pathol; 1999 Mar; 187(4):428-32. PubMed ID: 10398102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum.
    Ouyang H; Shiwaku HO; Hagiwara H; Miura K; Abe T; Kato Y; Ohtani H; Shiiba K; Souza RF; Meltzer SJ; Horii A
    Cancer Res; 1997 May; 57(10):1851-4. PubMed ID: 9157973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
    Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
    Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite Analysis of the Insulin-Like Growth Factor II Receptor in Colorectal Carcinomas.
    Souza RF; Meltzer SJ
    Methods Mol Med; 2001; 50():137-48. PubMed ID: 21318823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors.
    Osipo C; Dorman S; Frankfater A
    Exp Cell Res; 2001 Apr; 264(2):388-96. PubMed ID: 11262195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
    J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species.
    Jobling MF; Mott JD; Finnegan MT; Jurukovski V; Erickson AC; Walian PJ; Taylor SE; Ledbetter S; Lawrence CM; Rifkin DB; Barcellos-Hoff MH
    Radiat Res; 2006 Dec; 166(6):839-48. PubMed ID: 17149983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.
    Carethers JM; Pham TT
    In Vivo; 2000; 14(1):13-20. PubMed ID: 10757056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
    Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
    J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D3 metabolites regulate LTBP1 and latent TGF-beta1 expression and latent TGF-beta1 incorporation in the extracellular matrix of chondrocytes.
    Pedrozo HA; Schwartz Z; Mokeyev T; Ornoy A; Xin-Sheng W; Bonewald LF; Dean DD; Boyan BD
    J Cell Biochem; 1999 Jan; 72(1):151-65. PubMed ID: 10025676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.